Neovasc Profit Margin

The latest profit margin for NVCN is -1173.29% as of December 2022. That compares with -977.04% in the prior-year period — down 20.1% year over year. That is below the Healthcare sector average of 14.34%. Investors often review this figure alongside Neovasc's historical trend and sector peers before judging valuation or financial health.

Over the past year, NVCN's profit margin moved from -977.04% to -1173.29% — a 20.1% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Neovasc's valuation or profitability profile.

Against Healthcare companies, NVCN currently prints -1173.29% for profit margin, while the sector average sits near 14.34%. That is roughly 8279.2% below the sector mean. Large gaps often invite a closer look at Neovasc's growth, margins, and balance sheet.

Profit Margin shows how effectively Neovasc converts resources into returns. At -1173.29%, NVCN may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -977.04% in the prior-year period — down 20.1% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting NVCN's profit margin (-1173.29%), review year-over-year change from -977.04%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.